Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Christine Buerki"'
Autor:
Lorenzo Tosco, Annouschka Laenen, Thomas Gevaert, Isabelle Salmon, Christine Decaestecker, Elai Davicioni, Christine Buerki, Frank Claessens, Johan Swinnen, Karolien Goffin, Raymond Oyen, Wouter Everaerts, Lisa Moris, Gert De Meerleer, Karin Haustermans, Steven Joniau, P.E.A.R.L. (ProstatE cAncer Research Leuven)
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Recent retrospective data suggest that neoadjuvant androgen deprivation therapy can improve the prognosis of high-risk prostate cancer (PCa) patients. Novel androgen receptor pathway inhibitors are nowadays available for treatment
Externí odkaz:
https://doaj.org/article/d756a2c91f6b4917b75eee73727709ee
Autor:
Jennifer Mason Lobo, Adam P Dicker, Christine Buerki, Elai Daviconi, R Jeffrey Karnes, Robert B Jenkins, Nirav Patel, Robert B Den, Timothy N Showalter
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0116866 (2015)
BackgroundCurrently there is controversy surrounding the optimal way to treat patients with prostate cancer in the post-prostatectomy setting. Adjuvant therapies carry possible benefits of improved curative results, but there is uncertainty in which
Externí odkaz:
https://doaj.org/article/fe33227739274e62a74eeef941937665
Autor:
Nicholas Erho, Anamaria Crisan, Ismael A Vergara, Anirban P Mitra, Mercedeh Ghadessi, Christine Buerki, Eric J Bergstralh, Thomas Kollmeyer, Stephanie Fink, Zaid Haddad, Benedikt Zimmermann, Thomas Sierocinski, Karla V Ballman, Timothy J Triche, Peter C Black, R Jeffrey Karnes, George Klee, Elai Davicioni, Robert B Jenkins
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e66855 (2013)
Clinicopathologic features and biochemical recurrence are sensitive, but not specific, predictors of metastatic disease and lethal prostate cancer. We hypothesize that a genomic expression signature detected in the primary tumor represents true biolo
Externí odkaz:
https://doaj.org/article/880a5c46174d490ab5024790b6997a2b
Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findings
Autor:
Sarah M.C. Sittenfeld, Cristina Magi-Galluzzi, Marguerite du Plessis, Andrew J. Stephenson, Omar Y. Mian, Jennifer Bullen, Christine Buerki, Eric A. Klein, Anant Madabhushi, Elai Davicioni, Andrei S. Purysko, Lin Li
Publikováno v:
European Radiology. 29:4861-4870
We sought to evaluate the correlation between MRI phenotypes of prostate cancer as defined by PI-RADS v2 and the Decipher Genomic Classifier (used to estimate the risk of early metastases). This single-center, retrospective study included 72 nonconse
Autor:
S. Joniau, Christine Buerki, Christine Helsen, Y. Landesman, S. Soenen, Florian Handle, E. Davicioni, F. Claessens, T. Van Den Broeck, Wouter Everaerts, M. Jacquemyn, Dirk Daelemans, Lisa Moris
Publikováno v:
European Urology. 79:S610
Autor:
Tyler Kolisnik, Elai Davicioni, John W. Davis, Tamara L. Lotan, Neil E. Martin, Paul L. Nguyen, Sanoj Punnen, Eric A. Klein, Ashley E. Ross, Daniel E. Spratt, Radka Stoyanova, Felix Y. Feng, Alan Pollack, Christine Buerki, Kaye Ong, Samineh Deheshi, Jijumon Chelliserry, Zaid Haddad, Voleak Choeurng, Kasra Yousefi, Maria Aranes, Lucia L.C. Lam, Christopher J. Kane, Jeffrey J. Tosoian, Bruce J. Trock, Jennifer Margrave
Publikováno v:
European Urology. 72:845-852
Background Decipher is a validated genomic classifier developed to determine the biological potential for metastasis after radical prostatectomy (RP). Objective To evaluate the ability of biopsy Decipher to predict metastasis and Prostate cancer-spec
Autor:
Elai Davicioni, Firas Abdollah, Lucia L.C. Lam, Zaid Haddad, Edward M. Schaeffer, R. Jeffrey Karnes, Ashley E. Ross, Christine Buerki, Sheila Weinmann, Adam P. Dicker, Kasra Yousefi, Shuang G. Zhao, Felix Y. Feng, Voleak Choeurng, Andrew G. Glass, Robert B. Den, Bruce J. Trock, Jingbin Zhang, Daniel E. Spratt, Eric A. Klein, Samineh Deheshi, Stephen J. Freedland, Marguerite du Plessis
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 35, iss 18
Purpose To perform the first meta-analysis of the performance of the genomic classifier test, Decipher, in men with prostate cancer postprostatectomy. Methods MEDLINE, EMBASE, and the Decipher genomic resource information database were searched for p
Autor:
Christine Buerki, Lisa Moris, Thomas Van den Broeck, Jennifer Margrave, Christine Helsen, Lorenzo Tosco, Nick Fishbane, Edward M. Schaeffer, Steven Joniau, Frank Claessens, R. Jeffrey Karnes, John J. Davis, Sheila Weinmann, Robert B. Den, Wouter Everaerts, Elai Davicioni, Thomas Gevaert, Elien Smeets, Hendrik Van Poppel, Yang Liu
Background: Decipher is a genomic classifier designed to predict the development of distant metastases after surgical treatment of prostate cancer (PC). Its long-term prognostic role in a highrisk PC population has not been investigated previously. O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f961258b5b5841d1fd18d89d2b62b454
https://lirias.kuleuven.be/handle/123456789/635122
https://lirias.kuleuven.be/handle/123456789/635122
Autor:
Christine Buerki, Omar Y. Mian, Elai Davicioni, Cristina Magi-Galluzzi, Anant Madabhushi, Andrew J. Stephenson, Andrei S. Purysko, Eric A. Klein, Lin Li, Marguerite du Plessis, Jennifer Bullen
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:We sought to evaluate the correlation between MRI phenotypes of prostate cancer as defined by the Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) and D...
Autor:
Eila C. Skinner, Elai Davicioni, Lucia L. Lam, Peter C. Black, Nicholas Erho, Christine Buerki, M. Takhar, Anirban P. Mitra, Siamak Daneshmand, Roland Seiler
Publikováno v:
Journal of Urology. 196:1036-1041
Clinical staging in patients with muscle invasive bladder cancer misses up to 25% of lymph node metastasis. These patients are at high risk for disease recurrence and improved clinical staging is critical to guide management.Whole transcriptome expre